Roche
2021-4-13 · FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment Basel, 13 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the ...